Jim Cramer on Moderna, Inc. (MRNA): ‘The Numbers Here Are Staggering, Staggeringly Bad’
Jim Cramer, host of Mad Money, recently discussed the current state of the market and also discussed both the leading and ...
FiercePharma13h
Fierce Pharma Asia—A $410M obesity debut; Another Roche ADC deal; Legend, BeiGene as buyout targets?
A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...